Florida / New York

Medical Device News Magazine

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Agili-C Implant Receives FDA Breakthrough Device Designation: 251 Subjects Enrolled In IDE Clinical Study at 26 Sites in US, Europe and Israel

Medical Device News MagazineOctober 12, 2020August 30, 20210

The company is currently conducting a pivotal IDE clinical study which is designed to evaluate the Agili-C™ implant superiority over the current surgical standard of care – microfracture and debridement.

Request Information

Hours:

M – F 8 am – 5 pm

Florida / New York

Phone: 561.316.3330